AECL, Bechtel Forge Closer Ties on Advanced CANDU Reactor
WASHINGTON, Dec. 6 /PRNewswire-FirstCall/ -- Atomic Energy of Canada Limited (AECL) and Bechtel today announced they will work together on the deployment of the Advanced CANDU Reactor(TM) (ACR(TM)). AECL President and Chief Executive Officer Robert Van Adel and Bechtel Nuclear President James Reinsch said that AECL and Bechtel will establish a project team in Bechtel's Frederick, Maryland, office for the deployment of the ACR in the United States. According to Van Adel, the agreement combines AECL's expertise as an innovative technology developer and international project manager with Bechtel's premier engineering and project management skills. The ACR is an evolutionary design based on AECL's well-proven 700-megawatt class CANDU nuclear power plant. It features light-water coolant, heavy-water moderator, and slightly enriched fuel. The ACR represents a competitive package geared to a 36-month construction schedule. It currently is in preapplication review with the U.S. Nuclear Regulatory Commission and has a parallel licensing track with the Canadian Nuclear Safety Commission. Reinsch stated that "AECL and Bechtel have had a successful project with the construction of two CANDU 6 reactors at the Qinshan Phase III site in China. The new ACR agreement is as a logical extension of this relationship." First electricity has been generated by one unit in China and both units will go on line in 2003. The project is on budget and ahead of schedule. MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X35703558
More by this Source
Bechtel Ranks First On Top Contractors List
May 17, 2013, 16:18 ET
Bechtel Announces 2012 Business Results
May 17, 2013, 09:15 ET
Bechtel-Sponsored Teams Compete in FIRST Robotics World Championship
Apr 25, 2013, 09:24 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.